Literature DB >> 15213027

Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations.

Ahmad Aljada1, Husam Ghanim, Priya Mohanty, Tufail Syed, Arindam Bandyopadhyay, Paresh Dandona.   

Abstract

BACKGROUND: Glucose intake has been shown to cause an increase in intranuclear nuclear factor-kappa B and a decrease in inhibitor kappa B that are consistent with a proinflammatory effect. We investigated the effect of glucose intake on 2 other proinflammatory transcription factors, activator protein 1 (AP-1) and early growth response 1 (Egr-1), and on the genes regulated by them, ie, the genes for matrix metalloproteinases 2 (MMP-2) and 9 (MMP-9) and tissue factor (TF), respectively.
OBJECTIVE: The objective of the study was to ascertain whether the intake of 75 g glucose induces an increase in AP-1, Egr-1, and the genes regulated by them.
DESIGN: Eight healthy subjects were given 75 g glucose dissolved in 300 mL water to drink. Blood samples were collected before and 1, 2, and 3 h after glucose intake. Four weeks later, the same subjects were given 300 mL water sweetened with saccharine, and blood samples were collected at the same time points. Mononuclear cells (MNCs) were separated, and nuclear fractions were isolated.
RESULTS: AP-1 and Egr-1 binding activities were significantly higher 1 and 2 h after glucose intake and then decreased toward the baseline by 3 h. The expression of MMP-2 and TF in MNC homogenates also was significantly higher at 2 and 3 h. Plasma concentrations of MMP-2 were significantly higher at 3 h, whereas those of MMP-9 were significantly higher at 1, 2, and 3 h. In addition, TF was significantly higher at 2 and 3 h. Intake of saccharine-sweetened water had no significant effect on the inflammatory mediators measured in this study.
CONCLUSION: Glucose induces proinflammatory changes, including increases in AP-1, Egr-1, MMPs, and TF, the factors that regulate processes that are potentially relevant to atherosclerotic plaque rupture and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213027     DOI: 10.1093/ajcn/80.1.51

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  47 in total

1.  Diabetes and pancreatic cancer.

Authors:  Donghui Li
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  Tight perioperative glycemic control using an artificial endocrine pancreas.

Authors:  Kazuhiro Hanazaki; Hiromichi Maeda; Takehiro Okabayashi
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

Review 3.  Inflammatory lipid mediators in adipocyte function and obesity.

Authors:  Abishek Iyer; David P Fairlie; Johannes B Prins; Bruce D Hammock; Lindsay Brown
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

Review 4.  An overview of glycemic control in the coronary care unit with recommendations for clinical management.

Authors:  Mikhail Kosiborod; Prakash Deedwania
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

5.  Insulin infusion in acute illness.

Authors:  Paresh Dandona; Priya Mohanty; Ajay Chaudhuri; Rajesh Garg; Ahmad Aljada
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 6.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

7.  Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome.

Authors:  Frank González; John P Kirwan; Neal S Rote; Judi Minium
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-18       Impact factor: 4.310

8.  Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study.

Authors:  Omer T Njajou; Alka M Kanaya; Paul Holvoet; Stephanie Connelly; Elsa S Strotmeyer; Tamara B Harris; Steve R Cummings; Wen-Chi Hsueh
Journal:  Diabetes Metab Res Rev       Date:  2009-11       Impact factor: 4.876

9.  Inhibition of transcriptional activity of c-JUN by SIRT1.

Authors:  Zhanguo Gao; Jianping Ye
Journal:  Biochem Biophys Res Commun       Date:  2008-09-26       Impact factor: 3.575

Review 10.  The changing shape of type 2 diabetes.

Authors:  Stephen A Brunton
Journal:  Medscape J Med       Date:  2008-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.